Major Scope

  •  Lung Cancer
  •  Colorectal Cancer
  •  Pancreatic Cancer
  •  Breast Cancer
  •  Prostate Cancer
  •  Liver Cancer
  •  Leukemia
  •  Bladder Cancer
  •  Kidney Cancer
  •  Endometrial Cancer
  •  Oncology Case Reports
  •  Radiation Therapy

Abstract

Citation: Clin Oncol. 2017;2(1):1314.DOI: 10.25107/2474-1663-v2-id1314

Epigenetic Regulation of Hematological and Neurological Expressed 1(HN-1) at DU145 Brain Metastases Prostate Cancer Cell Line

Ceren Gonen-Korkmaz, Mehmet Zuhuri Arun, Buket Reel, Lokman Varıslı, Mazen Saeed Abdulaziz and Gokce YILDIRIM-BUHARALIOGLU

Department of Pharmacology, Ege University, Bornova, Izmir, Turkey
Department of Bioengineering, Cancer Biology Laboratory, Ege University, Bornova, Izmir, Turkey

*Correspondance to: Ceren Gonen-Korkmaz 

 PDF  Full Text Research Article | Open Access

Abstract:

Epigenetic investigates gene expression modifications not due to DNA sequence alterations. Gene expression modifications appear with packing of DNA with variety of chromatin structures. The most studied forms of epigenetic phenomenon are DNA methylation and histone modifications. These pathways are connected with each other and reversible. DNA methylation reported genes: 36B4 (as control), HN1 primers were used and methylation status had been confirmed at DU145 cell line. Histone modifications which close the gene expression is histone deacetylation had been reversed by Trichostatin A (TSA). It is reported that inhibition of methylation and deacetylation in a serial way result with successful gene activation, performed with 5 Azacitidine and TSA incubation at the project. In the recent years, epigenetic base had been shown for many diseases that research and development for epigenetic disorders won successful treatment cases. Preclinical and clinic levels of candidate drugs are on the way

Keywords:

HN1; DU145; TSA; 5-Azasitid

Cite the Article:

Gonen-Korkmaz C, Arun MZ, Reel B, Var?sl? L, Abdulaziz MS, YILDIRIMBUHARALIOGLU G. Epigenetic Regulation of Hematological and Neurological Expressed 1(HN-1) at DU145 Brain Metastases Prostate Cancer Cell Line. Clin Oncol. 2017; 2: 1314.

Journal Basic Info

  • Impact Factor: 3.231**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
  • PubMed NLM ID: 101705590

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Charlson Comorbidity Index as a Predictor of Cancer Mortality Beyond 10 Years after Radical Prostatectomy
 Abstract  PDF  Full Text
Ezrin Intracellular Cytoskeleton Marker is Over Expressed in Pancreatic Ductal Adenocarcinoma: A Prospective Cohort Study
 Abstract  PDF  Full Text
View More...